Trial
NCT04558125
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Cedars-Sinai Medical Center
Collaborators
Genentech, Inc.
Condition
Pulmonary Embolism
Intervention
TNKase
Why stopped
Identification of eligible patients was slower than anticipated.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-26